Related Experiment Videos
Composite lymphoma: a unique case with two immunologically distinct B-cell neoplasms
American Journal of Clinical Pathology
|April 1, 1984
Summary
A rare composite lymphoma, featuring two distinct B-cell lymphomas, was identified in a patient with rheumatoid arthritis. Immunohistology was crucial for diagnosing this complex malignancy, highlighting the role of autoimmune disease in its development.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease.
- Autoimmune conditions are associated with an increased risk of certain malignancies.
- Lymphomas can arise in the context of chronic inflammation and immune dysregulation.
Observation:
- A unique case of composite lymphoma was observed in a 69-year-old male patient with severe, long-standing rheumatoid arthritis.
- The lymphoma involved a single axillary lymph node.
- The neoplasm exhibited a dual B-cell lymphoma morphology: nodular poorly differentiated lymphocytic lymphoma (IgG-kappa) and diffuse well-differentiated lymphocytic lymphoma (IgM-lambda).
Findings:
- Immunohistologic studies confirmed the simultaneous presence of two distinct monoclonal lymphocyte proliferations within the lymph node.
- This composite lymphoma comprised two separate B-cell lymphomas with different immunoglobulin light chain expressions (kappa and lambda).
- The findings underscore the diagnostic challenge posed by composite lymphomas, which may be missed without advanced immunophenotyping.
Implications:
- This case highlights a potential link between long-standing autoimmune disease, such as rheumatoid arthritis, and the development of composite lymphomas.
- Immunohistochemistry is essential for accurate diagnosis and characterization of composite lymphomas, differentiating them from single lymphomas.
- Further research is warranted to elucidate the specific mechanisms by which autoimmune conditions may contribute to the genesis of such complex lymphoid malignancies.